academic article

• Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting..  Scientific reports.  7. 2017
• Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer. 2016
• Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes. 2016
• Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity..  The American journal of pathology.  :-. 2016
• Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release. 2016
• Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors. 2016
• The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease..  Science translational medicine.  7:-. 2015
• Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens..  Clinical cancer research : an official journal of the American Association for Cancer Research.  21:3041-3051. 2015
• PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. 2015
• Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer. 2015
• Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis. 2015
• Drug design strategies for the treatment of prostate cancer..  Expert opinion on drug discovery.  10:81-90. 2015
• Ligand-directed profiling of organelles with internalizing phage libraries..  Current protocols in protein science / editorial board, John E. Coligan ... [et al.].  79:30.4.1-30.4.30. 2015
• Receptor Tyrosine Kinase EphA5 is a Functional Molecular Target in Human Lung Cancer. 2015
• A multifunctional streptococcal collagen-mimetic protein coating prevents bacterial adhesion and promotes osteoid formation on titanium..  Acta biomaterialia.  10:3354-3362. 2014
• Design, development, and validation of a high-throughput drug-screening assay for targeting of human leukemia..  Cancer.  120:589-602. 2014
• Bone marrow-derived CD13(+) cells sustain tumor progression: A potential non-malignant target for anticancer therapy..  Oncoimmunology.  3:-. 2014
• CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis. 2013
• Targeting mammalian organelles with internalizing phage (iPhage) libraries..  Nature protocols.  8:1916-1939. 2013
• Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings..  Journal of controlled release : official journal of the Controlled Release Society.  170:233-241. 2013
• Tissue plasminogen activator regulates Purkinje neuron development and survival. 2013
• Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity..  Science translational medicine.  5:-. 2013
• Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78..  Clinical cancer research : an official journal of the American Association for Cancer Research.  19:2107-2116. 2013
• Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic. 2013
• A physical sciences network characterization of non-tumorigenic and metastatic cells..  Scientific reports.  3:-. 2013
• An antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosis. 2013
• Luminescent silica nanoparticles for cancer diagnosis..  Current medicinal chemistry.  20:2195-2211. 2013